"In all fairness, this is probably the spring of next year, if we talk about exports, this is when we have already reached a decent production volume in our country," he said.

"[Deliveries will begin] as the volume of vaccine production in our country increases and as our institutes, in particular Gamaleya, interact with foreign colleagues, because you need to go through a cycle of approbations in order to make a decision. ... Someone is ready to purchase it today, but we are not ready, because we need to fulfill our own tasks," Manturov explained.